CD Genomics
13 News & Press Releases found

CD Genomics news

CD Genomics, a renowned provider of genomics and bioinformatics services, is spearheading a new era of genomic research with its cutting-edge Transcriptomic Data Analysis service. This innovative service is poised to revolutionize the exploration of gene expression and regulation, offering researchers unparalleled insights into the intricate world of the transcriptome.

 

At the heart of CD Genomics'

Apr. 30, 2024

CD Genomics, a distinguished leader in genomics and sequencing services, has proudly unveiled its groundbreaking CRISPR Screen Sequencing technology. This innovative solution promises to expedite discoveries, facilitate target identification, and optimize drug development pipelines within the biotechnology and pharmaceutical industries.

 

CRISPR Screen Sequencing, a genome-wide screening technique, has

Oct. 21, 2023

CD Genomics, a globally recognized leader in genomics services, has recently unveiled its Complete Plasmid DNA Sequencing service, empowering researchers with cutting-edge solutions for genetic exploration. This service aims to provide scientists in various fields, such as molecular biology, genetics, and gene engineering, with exceptional support, enabling them to gain comprehensive insights into the intricacies of plasmid DNA.

&

Jun. 27, 2023

CD Genomics’ RNA-Solutions is a platform for revolutionary research in RNA, targeting coding and non-coding RNAs with different physiological functions. Based on rich RNA project experience and leading bioinformatics analytical capabilities, CD Genomics has launched a systematic solution for exosomal RNA research that assists in in-depth identification and functional analysis of exosomal mRNA, miRNA, lncRNA, etc.

Exosomes are microvesicles containing RNA and protein secreted by

Mar. 2, 2023

RNA-Solutions is a platform for revolutionary research in RNA, targeting coding and non-coding RNAs with different physiological functions. Scientists at CD Genomics are ready to help detect various types of RNAs via meticulous and integrative approaches. Recently, the company has launched m7G MeRIP sequencing to detect and analyze m7G RNA modification in a single sample, providing a powerful tool for research on intracellula

Dec. 26, 2022

MicrobioSeq is on behalf of the microbial genomics division of CD Genomics, headquartered in New York, USA. CD Genomics is a genomics service company with a renowned reputation for providing reliable sequencing, genotyping, microarray, and bioinformatics services. The company offers gene expression analysis services that identify phenotypic differences at the molecular level, provide insight into the role of d

Nov. 29, 2022

Methylation is one of the most classical epigenetic modifications in eukaryotes. DNA methylation regulates gene expression and has important implications in both growth and disease-related research. DNA methylation affects the maturation of germ cells or embryonic cells subject to specific gene expression. It has also been widely studied and applied to track aging and various forms of human disease. Various diseases, especially cancer have a pattern of DNA methylation that is not present in n

Oct. 10, 2022

MicrobioSeq represents the microbial genomics division of CD Genomics, headquartered in New York, USA. CD Genomics is a genomics service company with a good reputation for providing reliable sequencing, genotyping, microarray, and bioinformatics services. The company provides the long-read metagenomics sequencing service using PacBio SMRT platform, which can sequence multiple organisms in parallel with

Aug. 25, 2022

The RNA Solutions platform offers services to revolutionize RNA study, targeting both coding and non-coding RNAs of different physiological functions. Scientists at CD Genomics are ready to help detect various types of RNA via meticulous and integrative approaches. The company has recently launched the Nanopore direct RNA sequencing service for identifying new genes, transcripts, and alternative splicing events, as

Aug. 25, 2022

MicrobioSeq represents the microbial genomics division of CD Genomics, headquartered in New York, USA. CD Genomics is a genomics service company with a good reputation for providing reliable sequencing, genotyping, microarray, and bioinformatics services. To help scientists reveal the microbial community structure, evolutionary relationships of eukaryotes, and the correlation between eukaryotes and the environment, CD Genomics MicrobioSeq launched the

Jun. 28, 2022